| Dr Peter Michael Boruta, MD | |
|
3100 Cross Creek Pkwy, Suite 200, Auburn Hills, MI 48326-2774 | |
| (248) 377-8000 | |
| (248) 377-2929 |
| Full Name | Dr Peter Michael Boruta |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 53 Years |
| Location | 3100 Cross Creek Pkwy, Auburn Hills, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285601393 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 4301030726 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Providence - Crittenton Hospital Medical Center | Rochester, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rochester Knee And Sports Medicine Pc | 1355387564 | 26 |
News Archive
Mechanisms that govern HIV transcription and latency differ in the gut and blood, according to a study published November 15 in the open-access journal PLOS Pathogens by Steven Yukl of San Francisco Veterans Affairs Medical Center and the University of California, San Francisco, and colleagues.
Ambry Genetics today introduces their new StemArray™ product and services utilizing aCGH technology to cover the entire genome. The Ambry StemArray™ offers a higher resolution approach to standard karyotyping for stem cells at comparable costs.
Doubt has been cast over the current practice of administering intensive insulin therapy to all critically ill patients, according to a study published this week in the open access journal Critical Care. In certain groups of patients it could even be harmful.
GE Healthcare today announced it will expand its collaboration with The Health Management Academy (The Academy) over the next five years. This extended commitment emphasizes GE's dedication to working alongside the nation's health systems to address or eliminate challenges to delivering better health and outcomes to more people at lower cost.
Taiho Pharma Europe Ltd., a subsidiary of Japan based Taiho Pharmaceutical Co., Ltd., announced that it has submitted a Marketing Authorisation Application to the European Medicines Agency for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug intended for use in the treatment of refractory metastatic colorectal cancer (mCRC).
› Verified 2 days ago
| Entity Name | Rochester Knee & Sports Medicine Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295816460 PECOS PAC ID: 1355387564 Enrollment ID: O20050628000975 |
News Archive
Mechanisms that govern HIV transcription and latency differ in the gut and blood, according to a study published November 15 in the open-access journal PLOS Pathogens by Steven Yukl of San Francisco Veterans Affairs Medical Center and the University of California, San Francisco, and colleagues.
Ambry Genetics today introduces their new StemArray™ product and services utilizing aCGH technology to cover the entire genome. The Ambry StemArray™ offers a higher resolution approach to standard karyotyping for stem cells at comparable costs.
Doubt has been cast over the current practice of administering intensive insulin therapy to all critically ill patients, according to a study published this week in the open access journal Critical Care. In certain groups of patients it could even be harmful.
GE Healthcare today announced it will expand its collaboration with The Health Management Academy (The Academy) over the next five years. This extended commitment emphasizes GE's dedication to working alongside the nation's health systems to address or eliminate challenges to delivering better health and outcomes to more people at lower cost.
Taiho Pharma Europe Ltd., a subsidiary of Japan based Taiho Pharmaceutical Co., Ltd., announced that it has submitted a Marketing Authorisation Application to the European Medicines Agency for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug intended for use in the treatment of refractory metastatic colorectal cancer (mCRC).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Michael Boruta, MD 3100 Cross Creek Pkwy, Suite 200, Auburn Hills, MI 48326-2774 Ph: (248) 377-8000 | Dr Peter Michael Boruta, MD 3100 Cross Creek Pkwy, Suite 200, Auburn Hills, MI 48326-2774 Ph: (248) 377-8000 |
News Archive
Mechanisms that govern HIV transcription and latency differ in the gut and blood, according to a study published November 15 in the open-access journal PLOS Pathogens by Steven Yukl of San Francisco Veterans Affairs Medical Center and the University of California, San Francisco, and colleagues.
Ambry Genetics today introduces their new StemArray™ product and services utilizing aCGH technology to cover the entire genome. The Ambry StemArray™ offers a higher resolution approach to standard karyotyping for stem cells at comparable costs.
Doubt has been cast over the current practice of administering intensive insulin therapy to all critically ill patients, according to a study published this week in the open access journal Critical Care. In certain groups of patients it could even be harmful.
GE Healthcare today announced it will expand its collaboration with The Health Management Academy (The Academy) over the next five years. This extended commitment emphasizes GE's dedication to working alongside the nation's health systems to address or eliminate challenges to delivering better health and outcomes to more people at lower cost.
Taiho Pharma Europe Ltd., a subsidiary of Japan based Taiho Pharmaceutical Co., Ltd., announced that it has submitted a Marketing Authorisation Application to the European Medicines Agency for TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug intended for use in the treatment of refractory metastatic colorectal cancer (mCRC).
› Verified 2 days ago
Dr. Michael Augustine Yusaf, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3100 Cross Creek Pkwy, Suite 200, Auburn Hills, MI 48326 Phone: 248-377-8000 Fax: 248-377-2929 | |
Matthew Richard Prince, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3100 Cross Creek Pkwy, Suite 200, Auburn Hills, MI 48326 Phone: 248-377-8000 Fax: 248-377-2929 | |
Dr. Michael Patrick Donahue, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3100 Cross Creek Pkwy, Suite 200, Auburn Hills, MI 48326 Phone: 248-377-8000 Fax: 248-377-2929 | |
John R Olenyn, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3100 Cross Creek Pkwy, Suite 200, Auburn Hills, MI 48326 Phone: 248-377-8000 Fax: 248-377-2929 | |
John Eric Samani, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 937 N Opdyke Rd, Auburn Hills, MI 48326 Phone: 248-373-7600 Fax: 248-373-7443 | |
Dr. Allen L Babcock, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3100 Cross Creek Pkwy, Suite 200, Auburn Hills, MI 48326 Phone: 248-377-8000 Fax: 248-377-2929 |